News about Digitalization

Fischer Medical Ventures Strengthens AI Life Sciences Partnership with Nanyang Biologics

Fischer Medical Ventures and Nanyang Biologics are expanding their strategic collaboration to advance Artificial Intelligence (AI)-powered life sciences research and biotechnology innovation in India.

Digitalization | 14/07/2026 | By News Bureau

Evogene and Tel Aviv University Launch AI Drug Discovery Initiative

Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery have launched a joint initiative combining Artificial Intelligence (AI)-driven computational chemistry with advanced experimental capabilities to accelerate small-molecule drug discovery.

Digitalization | 08/07/2026 | By News Bureau |  106

SK Bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

SK bioscience has launched an Artificial Intelligence (AI)-powered initiative to improve vaccine development decisions, supporting next-generation injectable rotavirus vaccines and expanding access in Low- and Middle-Income Countries (LMICs).

Digitalization | 04/07/2026 | By News Bureau |  103

Insilico Medicine and Takeda Collaborate on AI Drug Discovery

Takeda and Insilico Medicine are collaborating to advance Artificial Intelligence (AI)-powered drug discovery, leveraging the Pharma.AI platform to accelerate the development of therapeutics.

Digitalization | 02/07/2026 | By News Bureau

IMU Biosciences Partners with Waters to Advance AI Immune Mapping Platform

IMU Biosciences has selected Waters to advance its Artificial Intelligence (AI)-powered immune mapping platform, accelerating early disease diagnosis, patient monitoring, and precision medicine development.

Digitalization | 26/06/2026 | By News Bureau |  192

Insilico Medicine And SK Biopharmaceuticals Achieve AI-Powered Drug Discovery Collaboration for Neuroimmune Disorders

Insilico Medicine and SK Biopharmaceuticals have entered an Artificial Intelligence (AI)-powered drug discovery collaboration worth up to USD 2.5 billion to develop innovative therapies for neuroimmune disorders.

Digitalization | 23/06/2026 | By News Bureau |  413

LG AI Research Partners with D&D Pharmatech for Oral Peptide Drug Discovery

LG AI Research and D&D Pharmatech have partnered to accelerate next-generation oral peptide drug discovery using advanced AI technologies. The collaboration aims to enhance drug development efficiency and strengthen LG’s leadership in the rapidly growing AI-driven biopharmaceutical market.

Digitalization | 18/06/2026 | By News Bureau |  100

Sophia Genetics Signs MoU with Memorial Sloan Kettering Cancer Center

Sophia Genetics has signed a strategic collaboration Memorandum of Understanding (MoU) with Memorial Sloan Kettering Cancer Center to establish a next-generation precision medicine hub.

Digitalization | 08/06/2026 | By News Bureau |  129

Owkin and Sanofi Partner to Develop AI Agents for Drug Discovery

Owkin and Sanofi have expanded their multi-year K Pro collaboration to develop AI agents that enhance drug discovery and development. By integrating agentic AI systems into research workflows, the partnership aims to unlock the full value of data, improve decision-making, and accelerate the development of innovative therapies.

Digitalization | 06/06/2026 | By News Bureau |  112

Sygnature Discovery Partners with DaltonTx to Advance AI-Driven Drug Discovery

Sygnature Discovery has partnered with DaltonTx to enhance Artificial Intelligence (AI)-enabled drug discovery capabilities, accelerating medicinal chemistry decision-making while maintaining robust data security standards to support faster and more efficient therapeutic research and development.

Digitalization | 05/06/2026 | By News Bureau |  131